Union Quimico Farmaceutica Sa (uquifa Sa), based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DOXYLAMINE SUCCINATE USP, with a corresponding US DMF Number 5399.
Remarkably, this DMF maintains an Active status since its submission on May 22, 1984, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2013, and payment made on August 01, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II